Rising Heart Attack Cases Fueling The Growth Of The Market Due To Demand For Rapid-Acting Emergency Medications Driving Market Acceleration in the Fast Melt Tablets Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Fast Melt Tablets Market Size By 2025?
The swift dissolving tablets market has seen a robust growth in the recent past. Its market value is forecasted to increase from $4.96 billion in 2024 to $5.33 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.5%. Several factors have been driving this growth during the historic period, including a surge in the aged population, a hike in chronic illnesses prevalence, an upswing in the trend for self-medication, growth of the pharmaceutical industry, and a rise in the amount of disposable income.

How Big Is the Fast Melt Tablets Market Size Expected to Grow by 2029?
Expectations are high for the fast melt tablets market to experience substantial growth in the coming years, expanding to reach a value of "$7.18 billion in 2029 with a compound annual growth rate (CAGR) of 7.7%. Factors contributing to future growth include the increasing incidence of dysphagia, a growing inclination towards OTC medications, enhanced presence of e-commerce, rising demand for orally disintegrating medications, and improvements in healthcare infrastructure. Anticipated trends during the forecast period involve technological progression, inventive formulation methods, the incorporation of nanotechnology, a shift towards excipients derived from plants, and intelligent drug delivery systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/fast-melt-tablets-global-market-report

Which Key Market Drivers Powering Fast Melt Tablets Market Expansion and Growth?
The growth of the fast melt tablets market is anticipated to be fueled by the escalating frequency of heart attacks. Considered a medical urgency, a heart attack happens when the blood supply to the heart muscle is interrupted, typically due to a blood clot or plaque accumulation in the coronary arteries. The frequency of heart attacks is on the rise because of the elevated intake of processed foods, which contributes to increased cholesterol levels and arterial plaque formation. Fast melt tablets facilitate rapid absorption of drugs, allowing for swift delivery of vital medicines such as aspirin or nitroglycerin. This expedites intervention during a heart attack, enhancing patient prognosis by reestablishing blood flow and diminishing the chance of substantial complications. For instance, the British Heart Foundation, a cardiovascular research charity based in the UK, reported in January 2024 that more than 39,000 individuals in England prematurely succumbed to cardiovascular diseases like heart attacks, coronary heart disease, and stroke in 2022, amounting to 750 deaths weekly. This number stands as the highest ever recorded. Thus, the growing frequency of heart attacks is fuelling the expansion of the fast melt tablets market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23398&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Fast Melt Tablets Market?
Leading firms in the fast melt tablets industry are concentrating on bringing innovative products to the market, such as fast dissolving tablets, in order to offer improved patient convenience as well as quicker drug absorption. Rapidly dissolving tablets, or RDTs, are essentially solid dosages designed to dissolve swiftly in the mouth without requiring any water. For example, Melt Pharmaceuticals, a clinical-stage pharmaceutical company based in the United States, introduced Melt 300 in December 2022. This advanced fast-melting tablet formulation is intended for efficient sedation. The formula combines 3mg of midazolam and 50mg of ketamine into a groundbreaking sublingual fast-melting tablet that dissolves without delay, offering quick onset and effective sedation without resorting to intravenous administration. Catering to the rising demand for needle-free, patient-friendly sedation methods, Melt 300 improves procedural comfort and optimizes clinical workflows.

What Are the Emerging Segments in the Fast Melt Tablets Market?
The fast melt tablets market covered in this report is segmented -

1) By Type: Anti Psychotics, Anti Epileptics, Central Nervous System (CNS) Stimulants, Anxiolytics, Anti Parkinsonian Drugs, Anti Hypertensive, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Anti Allergy Drugs, Proton Pump Inhibitors, Other Types
2) By Indication: Pain Management, Allergy And Respiratory Disorders, Neurological Disorders, Gastrointestinal Disorders, Cardiovascular Disorders, Other Indications
3) By Dosage Form: Oral, Sublingual, Buccal, Chewable
4) By Age Group: Adult, Pediatrics, Geriatrics
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By Anti Psychotics: Atypical Antipsychotics, Typical Antipsychotics
2) By Anti Epileptics: Sodium Channel Blockers, Gamma-Aminobutyric Acid (GABA) Analogs, Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazole Propionic Acid (AMPA) Receptor Antagonists, Carbonic Anhydrase Inhibitors
3) By Central Nervous System (CNS) Stimulants: Amphetamines, Methylphenidate, Modafinil, Xanthine Derivatives
4) By Anxiolytics: Benzodiazepines, Azapirones, Barbiturates, Antihistamines
5) By Anti Parkinsonian Drugs: Dopamine Agonists, Monoamine Oxidase-B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT) Inhibitors, Anticholinergics
6) By Anti Hypertensive: Beta Blockers, Calcium Channel Blockers, Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics
7) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDS): Cyclooxygenase-1 (COX-1) Inhibitors, Cyclooxygenase-2 (COX-2) Inhibitors
8) By Anti Allergy Drugs: Antihistamines, Leukotriene Receptor Antagonists, Mast Cell Stabilizers, Corticosteroids
9) By Proton Pump Inhibitors: Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole
10) By Other Types: Antiemetics, Antidepressants, Muscle Relaxants, Analgesics

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=23398&type=smp

Who Are the Global Leaders in the Fast Melt Tablets Market?
Major companies operating in the fast melt tablets market are Pfizer Inc., Johnson & Johnson, Fuji Chemical Industries Co. Ltd., Teva Pharmaceutical Industries Ltd., Church & Dwight* Co. Inc., Sun Pharmaceutical Industries Ltd, Catalent Inc., Aurobindo Pharma Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Centrient Pharmaceuticals B.V., Lannett Company Inc., Unichem Laboratories Ltd., SPI Pharma Inc., Windmill Health Products LLC, The Procter & Gamble Company, Perrigo Company plc, Melt Pharmaceuticals Inc., Imodium, Calpol, Akina Inc.

Which are the Top Profitable Regional Markets for the Fast Melt Tablets Industry?
North America was the largest region in the fast melt tablets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fast melt tablets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23398

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.